Sinopharm
1099.HK
#2482
Rank
โ‚น703.21 B
Marketcap
โ‚น225.34
Share price
-0.85%
Change (1 day)
18.92%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.613 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.613 Trillion. In 2024 the company made a revenue of โ‚น7.613 Trillion a decrease over the revenue in the year 2023 that were of โ‚น8.023 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.613 T-5.1%
2023โ‚น8.023 T5.42%
2022โ‚น7.610 T-2.1%
2021โ‚น7.773 T16.85%
2020โ‚น6.652 T14.95%
2019โ‚น5.787 T21.52%
2018โ‚น4.762 T5.93%
2017โ‚น4.495 T27.22%
2016โ‚น3.533 T5.37%
2015โ‚น3.353 T9.14%
2014โ‚น3.072 T17.22%
2013โ‚น2.621 T25.94%
2012โ‚น2.081 T34.61%
2011โ‚น1.546 T55.34%
2010โ‚น995.37 B35.79%
2009โ‚น733.03 B37.56%
2008โ‚น532.89 B31.43%
2007โ‚น405.47 B40.26%
2006โ‚น289.08 B